Valuation Kamada Ltd.

Stocks

Market Closed - TEL AVIV STOCK EXCHANGE 07:58:26 17/09/2026 pm IST			5-day change	1st Jan Change
2,633.00 ^ILa	+5.57%		+7.38%	+16.50%

17/09	Kamada Confirms Sufficient Kedrab Supply to Meet Increased Demand in the United States	CI
17/09	Kamada Maintains 'Sufficient' KedRAB Supply, Production Capacity Amid Increasing Rabies Exposures in US	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	920.4	615	1,280	1,271	1,304	1,520	-	-
Change	-	-33.18%	108.12%	-0.69%	2.55%	16.56%	-	-
Enterprise Value (EV)	920.4	615	1,280	1,271	1,304	1,520	1,520	1,520
Change	-	-33.18%	108.12%	-0.69%	2.55%	16.56%	0%	0%
P/E	-	-	-	-	-	-	-	-
PBR	-	-	-	-	-	-	-	-
PEG	-	-	-	-	-	-	-	-
Capitalization / Revenue	2.7x	1.31x	2.51x	2.17x	2.35x	2.51x	2.26x	2.08x
EV / Revenue	0x	0x	0x	0x	0x	2.51x	2.26x	2.08x
EV / EBITDA	-	-	0x	0x	0x	10x	7.68x	7.18x
EV / EBIT	-0x	0x	0x	0x	0x	15x	12.1x	10.7x
EV / FCF	-0x	-	-0x	0x	0x	25.8x	17x	12.5x
FCF Yield	-4.52%	-	-0.43%	10.5%	3.73%	3.88%	5.87%	7.98%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-	-	-	-	-	-	-	-
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	340.3	469.1	510.9	586.9	555.7	605.9	673.2	730.7
EBITDA ¹	-	-	86.36	124.5	129.3	151.9	197.9	211.5
EBIT ¹	-2.286	16.44	36.08	73.11	80.79	101	125.3	142.2
Net income ¹	-7.323	-8.417	29.7	52.73	62.2	84.8	104.1	118.1
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	20.55	13.72	22.27	22.11	22.60	26.33	26.33	26.33
Nbr of stocks (in thousands)	44,786	44,826	57,476	57,492	57,682	57,710	-	-
Announcement Date	15/03/22	15/03/23	06/03/24	05/03/25	11/03/26	-	-	-

¹ILS in Million²

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
KAMADA LTD.	-	-	-	-	50Cr
REGENERON PHARMACEUTICALS, INC.	18.28x	4.23x	9.95x	0.49%	7.88TCr
CSL LIMITED	20.79x	4.42x	13.68x	2.38%	6.05TCr
MODERNA, INC.	-18.86x	28.3x	-18.37x	-.--%	6.31TCr
SAMSUNG BIOLOGICS CO.,LTD.	34.01x	11.57x	22.18x	-.--%	4.67TCr
UCB	20.84x	4.61x	13.13x	0.7%	4.57TCr
BIOGEN INC.	35.73x	3.57x	13.39x	-.--%	3.24TCr
INCYTE CORPORATION	56.95x	3.64x	28.22x	-.--%	2.59TCr
INNOVENT BIOLOGICS, INC.	63.18x	6.76x	40.46x	-.--%	2.13TCr
SWEDISH ORPHAN BIOVITRUM AB	23.37x	5.01x	13.06x	-.--%	1.58TCr
Average	28.25x	8.01x	15.08x	0.4%	3.91TCr
Weighted average by Cap.	21.52x	9.15x	11.08x	0.55%